The ongoing trials, which were first initiated in the late last month, aim to manufacture a safer, non-prescription alternative to popular male enhancers such as Viagra, which can have serious side effects.
Clinical trials will be crucial to the process of fine-tuning the new formulas, according to the company.
NTRR CEO Michael-Shane Henderson said Neutra is pleased with what it has seen so far in these clinical trials and plans to push forward until it achieves the results it want.
"We believe we’re very close to perfecting an all-natural formula that both men and women will love," Henderson added.
"Side effects don’t belong in the bedroom, and we’re working hard to make sure we deliver a product that’s safe and effective."
Neutra develops and markets nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions.